These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6060574)

  • 1. Antiserum to ceramide lactoside hapten mixed with carrier protein.
    Tal C; Taketomi T; Yamakawa T
    Isr J Med Sci; 1967; 3(4):577-80. PubMed ID: 6060574
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative aspects of the binding of folic acid by folate antiserum.
    Rothenberg SP; Gizis F
    Cancer Res; 1971 Aug; 31(8):1095-9. PubMed ID: 5106916
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of an anti-hapten antibody response by an antiserum to the carrier protein.
    Pincus C; Miller G; Nussenzweig V
    J Immunol; 1973 Jan; 110(1):301-4. PubMed ID: 4685408
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and identification of antigenic conjugates of podophyllotoxin.
    Xu DM; Yu XY; Liu YQ; Feng JT; Ma JQ; Liu XJ; Zhang X
    Yao Xue Xue Bao; 2005 Jun; 40(6):518-24. PubMed ID: 16144316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies.
    Shimizu T; Osaka Y; Banri-Koike C; Yoshida M; Endo K; Furukawa K; Oda M; Murakami A; Ogawa S; Abe R; Azuma T
    Int Immunol; 2007 Oct; 19(10):1157-64. PubMed ID: 17881502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Univalent arsanilic acid derivatives as elicitors of passive cutaneous anaphylaxis.
    Rosenberg LT; Amkraut AA; Corp RB; Raffel S
    J Immunol; 1971 Oct; 107(4):1175-9. PubMed ID: 5093776
    [No Abstract]   [Full Text] [Related]  

  • 7. Variation in the size of antibody sites for the poly-L-aspartate hapten during the immune response.
    Murphy PD; Sage HJ
    J Immunol; 1970 Aug; 105(2):460-70. PubMed ID: 4988469
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of carrier and hapten array on the production of anti-hapten antibodies analyzed by two-dimensional affinity electrophoresis.
    Wang P; Nakamura K
    Electrophoresis; 1998 Jun; 19(8-9):1506-10. PubMed ID: 9694303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited heterogeneity of antibodies against the para-azobenzoate (X p ) hapten.
    Hoffman DR; Grossberg AL; Pressman D
    J Immunol; 1971 Aug; 107(2):325-30. PubMed ID: 5568764
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding characteristics of bovine serum albumin-aflatoxin B1 to polystyrene microtiter plates: importance of hapten to carrier protein molar ratio.
    Vyjayanthi V; Capoor AK; Sashidhar RB
    Indian J Exp Biol; 1995 May; 33(5):329-32. PubMed ID: 7558191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivators of hapten-coupled bacteriophages in normal sera.
    Jormalainen S
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(6):747-53. PubMed ID: 5290404
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic tolerance to sulfanilic acid assessed by the hapten-specific hemolytic plaque technique.
    Hraba T; Merchant B
    J Immunol; 1969 Jan; 102(1):229-40. PubMed ID: 5765456
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation of acetochlor antibody and its application on immunoaffinity chromatography cleanup for residue determination in peanuts.
    Chen Y; Wang X; Wang J; Tang S
    J Agric Food Chem; 2009 Sep; 57(17):7640-3. PubMed ID: 19681614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of anti-hapten IgE and IgG antibody responses by isologous anti-idiotypic antibodies against purified anti-carrier (ovalbumin) antibodies in BALB/c mice.
    Blaser K; Nakagawa T; de Weck AL
    J Immunol; 1981 Mar; 126(3):1180-4. PubMed ID: 7462630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic structure of Treponema: demonstration of a new lipid hapten in "Treponema reiteri". Study of human serums containing antibodies against this hapten].
    Dupouey P
    Ann Inst Pasteur (Paris); 1972 Feb; 122(2):283-95. PubMed ID: 5046459
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of hapten valency and carrier composition on the tolerogenic potential of hapten-protein conjugates.
    Pike BE; Battye FL; Nossal GJ
    J Immunol; 1981 Jan; 126(1):89-94. PubMed ID: 6161171
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and characterization of hapten-protein conjugates for antibody production against small molecules.
    Singh KV; Kaur J; Varshney GC; Raje M; Suri CR
    Bioconjug Chem; 2004; 15(1):168-73. PubMed ID: 14733597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential allotypic expression of anti-hapten response in first and second generation heterozygous rabbits of al,3 allotype.
    Zimmerman SE; Haurowitz F
    Immunochemistry; 1974 Aug; 11(8):403-7. PubMed ID: 4218587
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation of specific antisera to digoxin using hapten-[C-17]- and [C-12]-bovine serum albumin conjugates.
    Shimada K; Mizusawa S; Ohkubo T; Nambara T
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2301-6. PubMed ID: 6488402
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preparation and specificity of anti glyco-3 beta-hydroxy-5-cholen-24-oic acid C-3 bovine serum albumin (BSA) conjugate antiserum in radioimmunoassay (RIA)].
    Ikegawa S; Kinoshita J; Xu ZZ; Ohta M; Tohma M
    Yakugaku Zasshi; 1988 Oct; 108(10):979-83. PubMed ID: 3246642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.